DelMar Pharmaceuticals Inc (OTCQX US:DMPI)

0.7104
Delayed Data
As of 3:58pm ET
 -0.0296 / -4.00%
Today’s Change
0.62
Today|||52-Week Range
1.03
-12.30%
Year-to-Date
SECTOR
Distribution Services
INDUSTRY
Wholesale Distributors
MARKET CAP
$26.0M

Company Description

DelMar Pharmaceuticals, Inc. is a development stage company with a focus on the development of drugs for the treatment of cancer. Its products include VAL-083, Drug Discovery and Patents & Intellectual Property. DelMar Pharmaceuticals was founded by Jeffrey Bacha, Dennis M. Brown and William J. Garner on June 24, 2009 and is headquartered in Vancouver, Canada.

Contact Information

DelMar Pharmaceuticals, Inc.
999 West Broadway
Vancouver British Columbia V5Z 1K5
P:(604) 629-5989
Investor Relations:

Employees

Shareholders

Individual stakeholders18.39%
Mutual fund holders--
Other institutional--

Top Executives

Jeffrey A. BachaChairman, President & Chief Executive Officer
Scott PraillChief Financial Officer
Dennis M. BrownDirector & Chief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account